• FT-4202, FORMA’s Experimental SCD Therapy, Fares Well in Phase 1 Trial of Healthy Volunteers
  • Sickle Cell Patient Describes ‘Rebirth’ After Gene Therapy
  • More Life Hacks for Managing Sickle Cell
  • Emmaus Partners with US Bioservices to Offer SCD Patients New Treatment Adherence Program
  • FDA Grants Rare Pediatric Disease Status to Investigational Gene Therapy ARU-1801 for Sickle Cell
  • This Is What a Hospital Stay Looks Like
  • GBT and Syros Partner to Develop Sickle Cell Treatments That Boost Fetal Hemoglobin
  • Top 10 Sickle Cell Disease Stories of 2019
  • NIH Grant Backs Project to Develop New Pain Therapy for SCD Patients
  • These Apps Help Me Manage Sickle Cell
  • California Earmarks $15M for Expanding Care of Adult SCD Patients
  • Gene Therapy LentiGlobin Continues to Show Promising Results, Phase 1/2 Trial Data Shows